AXM Pharma Files Form 12b-25 With the Securities and Exchange Commission
2006年3月31日 - 12:50PM
ビジネスワイヤ(英語)
AXM Pharma, Inc. (AMEX: AXJ), a manufacturer of proprietary and
generic pharmaceutical and nutraceutical products for the Chinese
and other Asian markets, announced today that it has filed Form
12b-25 with the Securities and Exchange Commission granting the
Company a 15-day extension to file its Form 10-K. for the period
ended December 31, 2005. About AXM Pharma, Inc. AXM Pharma, Inc.,
through its wholly owned subsidiary, AXM Pharma Shenyang, Inc.
("AXM Shenyang"), is a manufacturer of proprietary and generic
pharmaceutical products, which include injectables, capsules,
tablets, liquids and medicated skin products for export and
domestic Chinese sales. AXM Shenyang is located in the City of
Shenyang, in the Province of Liaoning, China. AXM Shenyang has an
operating history of approximately 10 years. For additional
information on AXM Pharma Inc., please visit
http://www.axmpharma.com.
Axm (AMEX:AXJ)
過去 株価チャート
から 5 2024 まで 6 2024
Axm (AMEX:AXJ)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about Axm Pharma (アメリカ証券取引所): 0 recent articles
その他のAXM Pharma, Inc.ニュース記事